(Q36332217)

13 August 2017

1 reference

title

Alpha1-adrenergic blockers: current usage considerations (English)

1 reference

13 August 2017

Domenic A Sica

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Journal of Clinical Hypertension

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

757-762

1 reference

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Doxazosin inhibits proliferation and migration of human vascular smooth-muscle cells independent of alpha1-adrenergic receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Mild hypertension in the elderly. A comparison of prazosin and enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Effects of antihypertensive single-drug therapy on heart rate. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

ALLHAT: setting the record straight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Alpha-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Hyperinsulinemia, insulin resistance, and the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.05300.X

10.1111/J.1524-6175.2005.05300.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference